Eric Venker

CIK 1801917 · President & Immunovant CEO · last filed 2026-11-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$40.23M
Companies
3
Total Filings
178
Lifetime Open-Market Net
-$237.56M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

ROIV price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
C/O ROIVANT SCIENCES, INC.
7TH FLOOR, 50 BROADWAY
LONDON SW1H 0DB
Related Filers
Roivant Sciences Ltd. — 167 joint filings, latest 2026-10-02
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count in each company: direct shares plus every indirect holder (trusts, LLCs, partnerships, family members) on the latest Form 4 that lists them. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ROIV President & Immunovant CEO 811,211 $39.24 $31.83M -$213.62M 57 2026-11-12
IMVT Chief Executive Officer 257,075 $32.66 $8.40M -$581.4K 5 2026-10-05
Roivant Sciences Ltd. (ROIVW) Delisted President & COO 611,813 $2.75 $1.68M -$23.37M 32 2023-08-24

Recent Filings · Page 4 of 18

178 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144, so not all of them end in a sale. Under each notice: the role the filer ticked on it, and whether a sale followed (a Form 4 sale within 30 days, or a sale listed on a later notice).
Filed Symbol Action Net Shares Net $ Link
2026-01-14 ROIV Mixed10b5-1 — -$3.61M EDGAR
2026-01-12 ROIV Notice (144)
Officer · Planned Jan 12, 2026 · 10b5-1 plan
Sold: Form 4 filed Jan 14, 2026
−200,000 -$4.38M EDGAR
2025-12-29 ROIV Notice (144)
Officer · Planned Dec 24, 2025
Sold: Form 4 filed Dec 29, 2025
−75,000 -$1.69M EDGAR
2025-12-29 ROIV Mixed +156,689 -$4.52M EDGAR
2025-12-23 ROIV Notice (144)
Officer · Planned Dec 23, 2025
Sold: Form 4 filed Dec 29, 2025
−200,000 -$4.49M EDGAR
2025-12-11 ROIV Mixed10b5-1
Plan adopted Mar 28, 2025
— -$3.40M EDGAR
2025-12-09 ROIV Notice (144)
Officer · Planned Dec 9, 2025 · 10b5-1 plan
Sold: Form 4 filed Dec 11, 2025
−200,000 -$4.17M EDGAR
2025-11-24 ROIV Tax (F) −7,051 -$142.9K EDGAR
2025-11-07 ROIV Notice (144)
Officer · Planned Nov 7, 2025 · 10b5-1 plan
Sold: Form 4 filed Nov 7, 2025
−200,000 -$4.04M EDGAR
2025-11-07 ROIV Mixed10b5-1
Plan adopted Mar 28, 2025
— -$3.27M EDGAR
Showing 31–40 of 178
Page 4 of 18
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).

Sales Reported Only on Form 144

48 sales · $32.06M
Each Form 144 lists the seller's sales of the company's stock in the 3 months before it. These are the sales on this filer's notices that no Form 4 on file shows, which is the usual case once someone is no longer an officer or director, or for an affiliate who never files Form 4s. Each sale is listed once, with the first notice that reported it.
Sold Symbol Shares Proceeds Avg Price Listed On
2026-08-20 ROIV 13,909 $512.4K $36.84 2026-08-28
2026-02-20 ROIV 7,051 $191.4K $27.15 2026-03-17
2025-11-20 ROIV 7,051 $142.9K $20.27 2025-12-09
2024-09-20 ROIV 10,945 $131.0K $11.97 2024-12-20
2024-01-20 ROIV
Seller: Erik Venker
12,377 $128.1K $10.35 2024-02-09
2023-12-20 ROIV
Seller: Erik Venker
16,003 $159.4K $9.96 2024-02-09
2023-11-22 ROIV 16,549 $143.6K $8.68 2024-02-09
2023-10-24 ROIV 18,261 $164.2K $8.99 2023-11-21
2023-10-05 ROIV 153,027 $1.55M $10.11 2023-11-21
2023-08-22 ROIV
Seller: erik Venker
16,105 $174.4K $10.83 2023-09-01
2023-08-14 ROIV
Seller: erik Venker
59,811 $711.0K $11.89 2023-09-01
2023-08-14 ROIV 59,811 $711.2K $11.89 2023-08-21
2023-08-03 ROIV
Seller: Erik Venker
44,629 $532.3K $11.93 2023-08-14
2023-08-02 ROIV 16,397 $194.5K $11.86 2023-08-21
2023-08-02 ROIV
Seller: erik Venker
16,397 $194.4K $11.86 2023-08-03
2023-08-01 ROIV
Seller: Erik Venker
61,397 $732.1K $11.92 2023-08-02
2023-07-31 ROIV
Seller: Erik Venker
117,372 $1.40M $11.91 2023-08-01
2023-07-27 ROIV 23,622 $259.4K $10.98 2023-07-31
2023-07-26 ROIV 73,568 $802.6K $10.91 2023-08-21
2023-07-26 ROIV 28,344 $307.9K $10.86 2023-07-31
2023-07-26 ROIV 73,568 $802.8K $10.91 2023-07-27
2023-07-25 ROIV
Seller: Erick Venker
28,344 $307.9K $10.86 2023-07-26
2023-07-24 ROIV 16,297 $179.1K $10.99 2023-07-25
2023-07-24 ROIV 33,081 $361.6K $10.93 2023-07-25
2023-07-21 ROIV 181,998 $2.03M $11.13 2023-07-24
2023-07-21 ROIV 28,937 $322.1K $11.13 2023-07-24
2023-07-20 ROIV 159,387 $1.80M $11.31 2023-07-21
2023-06-22 ROIV 15,882 $159.0K $10.01 2023-07-20
2023-06-09 ROIV 299,384 $2.97M $9.91 2023-07-20
2023-06-09 ROIV 299,384 $2.97M $9.91 2023-06-21
2023-06-07 ROIV 201 $2.0K $9.85 2023-06-09
2023-05-23 ROIV 15,671 $150.1K $9.58 2023-06-07
2023-05-23 ROIV 415 $4.1K $9.85 2023-06-07
2023-05-22 ROIV 15,671 $150.1K $9.58 2023-06-02
2023-05-09 ROIV 238,724 $2.20M $9.23 2023-06-21
2023-05-09 ROIV 238,724 $2.20M $9.23 2023-05-22
2023-05-08 ROIV 61,206 $546.2K $8.92 2023-05-09
2023-05-04 ROIV 88,838 $737.5K $8.30 2023-05-08
2023-05-03 ROIV 118,760 $997.2K $8.40 2023-05-04
2023-05-02 ROIV 109,074 $897.5K $8.23 2023-05-03
2023-05-01 ROIV 61,155 $525.3K $8.59 2023-05-02
2023-04-28 ROIV 75,823 $641.9K $8.47 2023-05-01
2023-04-27 ROIV 73,514 $625.9K $8.51 2023-04-28
2023-04-26 ROIV 72,906 $631.7K $8.66 2023-04-27
2023-03-23 ROIV 14,194 $103.6K $7.30 2023-06-21
2023-03-21 ROIV 14,194 $103.6K $7.30 2023-05-22
2023-03-20 ROIV 28,936 $252.0K $8.71 2023-04-26
2023-02-21 ROIV 28,939 $249.5K $8.62 2023-04-26